176 related articles for article (PubMed ID: 32996057)
1. Discovery of a stable tripeptide targeting the N-domain of CRF1 receptor.
Liapakis G; Karageorgos V; Andreadelis I; Holz GG; Dermitzaki E; Kordopati GG; Stylos EΚ; Spyridaki K; Poulaki S; Ntountaniotis D; Sakellaris S; Vanioti M; Kostagianni A; Marousis KD; Leonis G; Kokotos G; Venihaki M; Spyroulias GA; Tselios T; Margioris A; Tzakos AG; Mavromoustakos T
Amino Acids; 2020 Sep; 52(9):1337-1351. PubMed ID: 32996057
[TBL] [Abstract][Full Text] [Related]
2. Selective antagonism of CRF1 receptor by a substituted pyrimidine.
Sakellaris S; Matsoukas MT; Karageorgos V; Poulaki S; Kuppast B; Margioris A; Venihaki M; Fahmy H; Liapakis G
Hormones (Athens); 2019 Jun; 18(2):215-221. PubMed ID: 30980254
[TBL] [Abstract][Full Text] [Related]
3. Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors.
Tasma Z; Wills P; Hay DL; Walker CS
Pharmacol Res Perspect; 2020 Jun; 8(3):e00595. PubMed ID: 32529807
[TBL] [Abstract][Full Text] [Related]
4. Structural-functional analysis of the third transmembrane domain of the corticotropin-releasing factor type 1 receptor: role in activation and allosteric antagonism.
Spyridaki K; Matsoukas MT; Cordomi A; Gkountelias K; Papadokostaki M; Mavromoustakos T; Logothetis DE; Margioris AN; Pardo L; Liapakis G
J Biol Chem; 2014 Jul; 289(27):18966-77. PubMed ID: 24838244
[TBL] [Abstract][Full Text] [Related]
5. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
McCarthy JR; Heinrichs SC; Grigoriadis DE
Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
[TBL] [Abstract][Full Text] [Related]
6. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
Myers DA; Trinh JV; Myers TR
Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
[TBL] [Abstract][Full Text] [Related]
8. Functional, endogenously expressed corticotropin-releasing factor receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH-SY5Y cells.
Schoeffter P; Feuerbach D; Bobirnac I; Gazi L; Longato R
Fundam Clin Pharmacol; 1999; 13(4):484-9. PubMed ID: 10456290
[TBL] [Abstract][Full Text] [Related]
9. A role of noradrenergic receptors in anxiolytic-like effect of high CRF in the rat frontal cortex.
Śmiałowska M; Zięba B; Domin H
Neuropeptides; 2021 Aug; 88():102162. PubMed ID: 34062382
[TBL] [Abstract][Full Text] [Related]
10. [¹²⁵I]YP20: a novel radioligand specific for the extracellular domain of the CRF₁ receptor.
Gordon JC; Edwards P; Elmore CS; Lazor LA; Paschetto K; Bostwick R; Sylvester M; Mauger R; Scott C; Aharony D
Eur J Pharmacol; 2010 Dec; 649(1-3):59-63. PubMed ID: 20854803
[TBL] [Abstract][Full Text] [Related]
11. CRF
Parra-Mercado GK; Fuentes-Gonzalez AM; Hernandez-Aranda J; Diaz-Coranguez M; Dautzenberg FM; Catt KJ; Hauger RL; Olivares-Reyes JA
Front Endocrinol (Lausanne); 2019; 10():869. PubMed ID: 31920979
[TBL] [Abstract][Full Text] [Related]
12. Extended Amygdala to Ventral Tegmental Area Corticotropin-Releasing Factor Circuit Controls Binge Ethanol Intake.
Rinker JA; Marshall SA; Mazzone CM; Lowery-Gionta EG; Gulati V; Pleil KE; Kash TL; Navarro M; Thiele TE
Biol Psychiatry; 2017 Jun; 81(11):930-940. PubMed ID: 27113502
[TBL] [Abstract][Full Text] [Related]
13. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
[TBL] [Abstract][Full Text] [Related]
14. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
[TBL] [Abstract][Full Text] [Related]
15. Non-peptidic CRF1 receptor antagonists for the treatment of anxiety, depression and stress disorders.
Kehne J; De Lombaert S
Curr Drug Targets CNS Neurol Disord; 2002 Oct; 1(5):467-93. PubMed ID: 12769601
[TBL] [Abstract][Full Text] [Related]
16. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
[TBL] [Abstract][Full Text] [Related]
17. The involvement of CRF1 receptor within the basolateral amygdala and dentate gyrus in the naloxone-induced conditioned place aversion in morphine-dependent mice.
Valero E; Gómez-Milanés I; Almela P; Ribeiro Do Couto B; Laorden ML; Milanés MV; Núñez C
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):102-114. PubMed ID: 29407532
[TBL] [Abstract][Full Text] [Related]
18. Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaine.
Navarro G; Quiroz C; Moreno-Delgado D; Sierakowiak A; McDowell K; Moreno E; Rea W; Cai NS; Aguinaga D; Howell LA; Hausch F; Cortés A; Mallol J; Casadó V; Lluís C; Canela EI; Ferré S; McCormick PJ
J Neurosci; 2015 Apr; 35(17):6639-53. PubMed ID: 25926444
[TBL] [Abstract][Full Text] [Related]
19. Lack of interaction between etifoxine and CRF1 and CRF2 receptors in rodents.
Verleye M; André N; Gillardin JM
Neurosci Res; 2006 Sep; 56(1):53-60. PubMed ID: 16769145
[TBL] [Abstract][Full Text] [Related]
20. Progress in corticotropin-releasing factor-1 antagonist development.
Zorrilla EP; Koob GF
Drug Discov Today; 2010 May; 15(9-10):371-83. PubMed ID: 20206287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
